Yüklüyor......
Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD
BACKGROUND: The clinical efficacy of short-acting β(2)-agonists administered before performing daily activities in chronic obstructive pulmonary disease (COPD) is unclear. The aim of this study was to investigate the clinical effect of supplementary inhaled procaterol hydrochloride in patients with...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3396116/ https://ncbi.nlm.nih.gov/pubmed/22807639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S20833 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|